# Healthcare stocks to buy

> Three healthcare stocks with strong growth potential.
- Title: Healthcare stocks to buy · MoneyWeek | Shortify
- Summary: Three healthcare stocks with strong growth potential. Eli Lilly, Bayer, and CareDx offer innovative healthcare solutions with significant growth…
- Keywords: elijilly, bayer, caredx, glp-1s, tirzepatide, mounjaro, zepbound, nubeqa, kerendia, asundexian, allosure, navdx
- Source: MoneyWeek — https://moneyweek.com/investments/biotech-stocks/three-healthcare-stocks-to-buy
- Published: 2026-10-19T07:30:00+00:00
- Read time: 1 min
- Topics: elijilly, bayer, caredx, glp-1s, tirzepatide, mounjaro, zepbound, nubeqa, kerendia, asundexian, allosure, navdx
## Worldwide Healthcare Trust
The Worldwide Healthcare Trust offers a bottom-up approach to stock selection with innovation and growth focus.
## GLP-1s drugs
Eli Lilly's GLP-1s drugs like tirzepatide offer weight loss and blood-sugar control with additional health benefits.
## Tirzepatide benefits
Tirzepatide treats cardiovascular, kidney, liver disease, sleep apnea, arthritic pain and may improve cognitive health.
## Eli Lilly innovations
Eli Lilly is developing oral versions and next-generation injectables for improved efficacy and tolerability.
## Bayer's pharmaceutical growth
Bayer's pharmaceuticals show strong growth in prostate cancer and kidney disease treatments.
## Bayer's asundexian
Bayer's asundexian reduces recurrent stroke risk by 26% in high-risk patients.
## CareDx growth
CareDx shows 50% revenue growth and over 500% earnings growth in second quarter.
## Key takeaway

Eli Lilly, Bayer, and CareDx offer innovative healthcare solutions with significant growth opportunities.